Skip to main content
OpenTrials
Completed

NCT Number: NCT04863716

Erector Spinae Plane Block in Renal Transplantation Donors

Erector Spina Plan Block (ESPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. Studies showing the clinical benefits of Erector Spina Plan block in renal transplantation surgery are limited to case reports. In this study, the effect of Erector Spina Plan Block on opioid consumption in postoperative period on donor patients who will undergo laparoscopic nephrectomy in renal transplantation surgery will be examined prospectively.

The aim of the study is to provide analgesia to donor patients using less opioids by Erector Spina Plan Block and provide enhanced recovery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Transplantation Erector Spinae Plane Block Laparoscopic Nephrectomy

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Koç University Hospital

Istanbul, Zeytinburnu, 34010, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Donor patients scheduled for elective nephrectomy in renal transplantation surgery
  • ASA I-II
  • Patients who are aged between 18-75

Exclusion criteria

  • Skin infection at the Erector Spina Plan Block area
  • Coagulation disorder or using anticoagulant drugs
  • End-stage organ and system failure
  • Severe pulmonary and/or cardiovascular problems
  • Substance addiction or known psychiatric or mental problems
  • Chronic painkiller usage

Treatment and study plan

Erector Spinae Plane Block

Procedure

Erector Spinae Plane Block will be administered before the surgery.

Intravenous fentanyl patient control device

Procedure

24-hour fentanyl consumption will be recorded.

Primary outcomes

  1. Fentanyl consumption

    Time frame: Postoperative 24 hours

    The amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours.

Secondary outcomes

  1. Visual Analog Scale

    Time frame: Postoperative 24 hours

    Pain of patients will be evaluated and recorded according to the Visual Analog Scale.

  2. Modified Aldrete Score

    Time frame: Postoperative 1 hour

    Modified Aldrete Score will be used in patient recovery, and scores will be recorded at 5 minute intervals.

Sponsors and collaborators

Lead sponsor

Koc University Hospital

Other

Registry information

Official study title

Effects of Erector Spinae Plane Block on Opioid Consumption in Renal Transplantation Donors

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Apr 28, 2021
Registry last updated
Sep 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.